H, F., X, W., W, W., H, L., H, X., Y, W., . . . Z, B. (2026). Meningeal immunity and "Interstitial" therapy: A new paradigm for immunotherapy in glioblastoma. Frontiers in immunology, 17, 1847377. https://doi.org/10.3389/fimmu.2026.1847377
Chicago Style (17th ed.) CitationH, Fei, Wen X, Wu W, Liu H, Xie H, Wang Y, Zheng K, Zeng Z, and Bai Z. "Meningeal Immunity and "Interstitial" Therapy: A New Paradigm for Immunotherapy in Glioblastoma." Frontiers in Immunology 17 (2026): 1847377. https://doi.org/10.3389/fimmu.2026.1847377.
MLA (9th ed.) CitationH, Fei, et al. "Meningeal Immunity and "Interstitial" Therapy: A New Paradigm for Immunotherapy in Glioblastoma." Frontiers in Immunology, vol. 17, 2026, p. 1847377, https://doi.org/10.3389/fimmu.2026.1847377.